Is the supplementation with antioxidants effective in the treatment of atherosclerosis?;Sind Antioxidantien zur Behandlung der Atherosklerose sinnvoll?

Deutsche Medizinische Wochenschrift

Volumn 129, Issue 7, 2004, Pages 321-326

  Schroder St ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Abteilung für Kardiologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BETA TOCOPHEROL; FLAVONOID; GAMMA TOCOPHEROL; NITRIC OXIDE SYNTHASE; PROBUCOL; RAMIPRIL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RETINOL; SUPEROXIDE DISMUTASE; UBIQUINONE;

ATHEROSCLEROSIS; CANCER PREVENTION; CLINICAL TRIAL; FOLLOW UP; HEALTH STATUS; HEART PROTECTION; HUMAN; NURSING; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; RISK FACTOR;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; ARTERIOSCLEROSIS; ASCORBIC ACID; ASPIRIN; BETA CAROTENE; CARDIOVASCULAR DISEASES; CONTROLLED CLINICAL TRIALS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; FREE RADICALS; HUMANS; MALE; NUTRITION PHYSIOLOGY; OXIDATIVE STRESS; PLACEBOS; PLATELET AGGREGATION INHIBITORS; PRIMARY PREVENTION; PROSPECTIVE STUDIES; RAMIPRIL; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; TIME FACTORS; TOCOPHEROLS; VITAMINS;

EID: 1342344023     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818629     Document Type: Review

References (42)

1. Routine vitamin supplementation to prevent cancer and cardiovascular disease. Recommendations and rationale. Ann Intern Med 2003; 139: 51-55
2. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000; 356: 1213-1218
3. Brasen JH, Koenig K, Bach H, Kontush A, Heinle H, Witting PK et al. Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits. Atherosclerosis 2002; 163: 249-259
4. Brigelius-Flohe R, Kelly FJ, Salonen JT, Neuzil J, Zingg JM, Azzi A. The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr 2002; 76: 703-716
5. Brown BG, Cheung MC, Lee AC, Zhao XQ, Chait A. Antioxidant vitamins and lipid therapy: end of a long romance? Arterioscler Thromb Vasc Biol 2002; 22: 1535-1546
6. de Gaetano G. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 2001; 357: 89-95
7. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 99: 779-785
8. Diaz MN, Frei B, Vita JA, Jr. Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337: 408-416
9. Drexler H. Endothelfunktion bei kardiovaskulären Erkrankungen. UNI-MED Verlag Bremen, 2000
10. Fayad ZA, Fuster V, Nikolaou K, Becker C. Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future concepts. Circulation 2002; 106: 2026-2034
11. Frei B. To C or not to C, that is the question!. J Am Coll Cardiol 2003; 42: 253-255
12. Gaytan RJ, Prisant LM. Oral nutritional supplements and heart disease: a review. Am J Ther 2001; 8: 255-274
13. GISSI-Study group. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999; 354: 447-455
14. Harris A, Devaraj S, Jialal I. Oxidative Stress, Alpha-tocopherol Therapy, and Atherosclerosis. Curr Atheroscler Rep 2002; 4: 373-380
15. Hein HO, Suadicani P, Gyntelberg F. Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: six year follow up in the Copenhagen male study. BMJ 1996; 312: 736-741
16. Heinecke JW. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis. Arterioscler Thromb Vasc Biol 2001; 21: 1261-1264
17. Heinecke JW. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol 2003; 91: 12A-16A
18. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678
19. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-1149
20. Hornig B. Vitamins, antioxidants and endothelial function in coronary artery disease. Cardiovasc Drugs Ther 2002; 16: 401-409
21. HPS-Study Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 23-33
22. Jialal I, Devaraj S. Antioxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation 2003; 107: 926-928
23. Jr. Keaney JF, Vita JA. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog Cardiovasc Dis 1995; 38: 129-154
24. Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 1996; 312: 478-481
25. Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol 2003; 91: 3A-6A
26. Littarru GP. Energie und Schutz. Casa Editrice Scientifica Internazionale, Rom, 1994
27. Morris CD, Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003; 139: 56-70
28. Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Hu FB, Manson JE et al. Vitamin C and risk of coronary heart disease in women. J Am Coll Cardiol 2003; 42: 246-252
29. Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997; 349: 1715-1720
30. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-1456
31. Salonen RM, Nyyssonen K, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Rissanen TH et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 2003; 107: 947-953
32. Schroeder S, Kopp AF, Baumbach A, Meisner C, Kuettner A, Georg C et al. Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography. J Am Coll Cardiol 2001; 37: 1430-1435
33. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-1449
34. Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 2002; 105: 2107-2111
35. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-786
36. Terentis AC, Thomas SR, Burr JA, Liebler DC, Stocker R. Vitamin E oxidation in human atherosclerotic lesions. Circ Res 2002; 90: 333-339
37. Thomas SR, Leichtweis SB, Pettersson K, Croft KD, Mori TA, Brown AJ et al. Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol 2001; 21: 585-593
38. U.S.Preventive Task Force. Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale. Ann Intern Med 2003; 139: 51-55
39. Virtamo J, Rapola JM, Ripatti S, Heinonen OP, Taylor PR, Albanes D et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med 1998; 158: 668-675
40. Wasserman MA, Sundell CL, Kunsch C, Edwards D, Meng CQ, Medford RM. Chemistry and pharmacology of vascular protectants: a novel approach to the treatment of atherosclerosis and coronary artery disease. Am J Cardiol 2003; 91: 34A-40A
41. Willett WC, Stampfer MJ. Clinical practice. What vitamins should I be taking, doctor? N Engl J Med 2001; 345: 1819-1824
42. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 154-160